FDA advisory panel endorses Moderna booster shots for older, high-risk adults

October 14, 2021

A key independent Food and Drug Administration (FDA) panel has endorsed booster shots of Moderna’s COVID-19 vaccine for certain groups of Americans.

The advisers to the FDA voted Thursday to recommend a lower-dose booster shot for seniors and other high-risk groups, similar to how they endorsed boosters for Pfizer’s COVID-19 vaccine a few weeks ago.

Before the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) made its endorsement, it met Thursday to discuss the benefits and risks of recommending booster shots for Moderna’s COVID-19 vaccine.

According to ABC News, now that the panel has voted to recommend booster shots for Moderna, the matter will now head to the FDA as a whole.

If the FDA then issues a formal recommendation, the question will be posed to the Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices, which already has meetings scheduled to discuss Moderna boosters on Oct. 20 and Johnson & Johnson boosters on Oct. 21. Finally, CDC Director Dr. Rochelle Walensky will need to issue a final recommendation for full approval.

ABC News estimates the earliest the booster shots could be approved for emergency use would be Oct. 22.

Read more at ABC News